1. The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops
- Author
-
R. Matthew Kottmann, A.R. Rackow, Patricia J. Sime, David J. Nagel, Jennifer L. Judge, Shannon Lacy, Claire E. McCarthy, Thomas H. Thatcher, and Margaret A.T. Freeberg
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Pulmonary Fibrosis ,Disease ,Article ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,Pulmonary fibrosis ,medicine ,Humans ,Pathological ,Lung ,Cellular Senescence ,business.industry ,Mechanism (biology) ,Epithelial Cells ,medicine.disease ,Idiopathic Pulmonary Fibrosis ,030104 developmental biology ,medicine.anatomical_structure ,Signalling ,030228 respiratory system ,business ,Neuroscience ,Progressive disease ,Signal Transduction - Abstract
Pulmonary fibrosis is a devastating, progressive disease and carries a prognosis worse than most cancers. Despite ongoing research, the mechanisms that underlie disease pathogenesis remain only partially understood. However, the self-perpetuating nature of pulmonary fibrosis has led several researchers to propose the existence of pathological signalling loops. According to this hypothesis, the normal wound-healing process becomes corrupted and results in the progressive accumulation of scar tissue in the lung. In addition, several negative regulators of pulmonary fibrosis are downregulated and, therefore, are no longer capable of inhibiting these feed-forward loops. The combination of pathological signalling loops and loss of a checks and balances system ultimately culminates in a process of unregulated scar formation. This review details specific signalling pathways demonstrated to play a role in the pathogenesis of pulmonary fibrosis. The evidence of detrimental signalling loops is elucidated with regard to epithelial cell injury, cellular senescence and the activation of developmental and ageing pathways. We demonstrate where these loops intersect each other, as well as common mediators that may drive these responses and how the loss of pro-resolving mediators may contribute to the propagation of disease. By focusing on the overlapping signalling mediators among the many pro-fibrotic pathways, it is our hope that the pulmonary fibrosis community will be better equipped to design future trials that incorporate the redundant nature of these pathways as we move towards finding a cure for this unrelenting disease.
- Published
- 2020